Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42. (Q38037154)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 2012

Language	Label	Description	Also known as
English	Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.	scientific article published on August 2012

Statements

scholarly article

1 reference

Europe PubMed Central

27 August 2017

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42. (English)

1 reference

Europe PubMed Central

27 August 2017

0 references

Alzheimer's disease

0 references

cerebrospinal fluid

0 references

Henrik Zetterberg

28

object named as

Henrik Zetterberg

1 reference

Europe PubMed Central

27 August 2017

29

object named as

Kaj Blennow

1 reference

Europe PubMed Central

27 August 2017

object named as

Josef Pannee

19

0 references

Marinus Blankenstein

object named as

Marinus A Blankenstein

5

0 references

Maria C Carrillo

7

object named as

Maria C Carrillo

1 reference

Europe PubMed Central

27 August 2017

Charlotte Teunissen

24

object named as

Charlotte E Teunissen

1 reference

Europe PubMed Central

27 August 2017

30

object named as

Erik Portelius

1 reference

Europe PubMed Central

27 August 2017

Niklas Mattsson

1

object named as

Niklas Mattsson

1 reference

Europe PubMed Central

27 August 2017

4

object named as

Maria Bjerke

1 reference

Europe PubMed Central

27 August 2017

3

object named as

Ulf Andreasson

1 reference

Europe PubMed Central

27 August 2017

Hugo Vanderstichele

27

object named as

Hugo Vanderstichele

1 reference

Europe PubMed Central

27 August 2017

Michael P T Lunn

16

object named as

Michael P Lunn

1 reference

Europe PubMed Central

27 August 2017

25

object named as

Marcel M Verbeek

1 reference

Europe PubMed Central

27 August 2017

8

object named as

Johan Gobom

1 reference

Europe PubMed Central

27 August 2017

23

object named as

Holly Soares

1 reference

Europe PubMed Central

27 August 2017

Andreas Jeromin

11

object named as

Andreas Jeromin

1 reference

Europe PubMed Central

27 August 2017

13

object named as

Daniel Kidd

1 reference

Europe PubMed Central

27 August 2017

26

object named as

Robert M Umek

1 reference

Europe PubMed Central

27 August 2017

2

object named as

Ingrid Zegers

1 reference

Europe PubMed Central

27 August 2017

6

object named as

Robert Bowser

1 reference

Europe PubMed Central

27 August 2017

10

object named as

Rand Jenkins

1 reference

Europe PubMed Central

27 August 2017

14

object named as

Omar F Laterza

1 reference

Europe PubMed Central

27 August 2017

author name string

Theresa Heath

9

1 reference

Europe PubMed Central

27 August 2017

June Kaplow

12

1 reference

Europe PubMed Central

27 August 2017

Andrew Lockhart

15

1 reference

Europe PubMed Central

27 August 2017

Robert L Martone

17

1 reference

Europe PubMed Central

27 August 2017

Kevin Mills

18

1 reference

Europe PubMed Central

27 August 2017

Marianne Ratcliffe

20

1 reference

Europe PubMed Central

27 August 2017

Leslie M Shaw

21

1 reference

Europe PubMed Central

27 August 2017

Adam J Simon

22

1 reference

Europe PubMed Central

27 August 2017

publication date

1 August 2012

1 reference

Europe PubMed Central

27 August 2017

Biomarkers in Medicine

1 reference

Europe PubMed Central

27 August 2017

6

1 reference

Europe PubMed Central

27 August 2017

4

1 reference

Europe PubMed Central

27 August 2017

409-417

1 reference

Europe PubMed Central

27 August 2017

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Revising the definition of Alzheimer's disease: a new lexicon.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Age and diagnostic performance of Alzheimer disease CSF biomarkers.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Association study of clusterin polymorphism rs11136000 with late onset Alzheimer's disease in Chinese Han population

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

International quality control survey of neurochemical dementia diagnostics.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β((1-42)), Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International Workshop

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

High education may offer protection against tauopathy in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Standardizing plasma protein measurements worldwide: a challenging enterprise

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

The importance of metrological traceability on the validity of creatinine measurement as an index of renal function.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Standardization in clinical enzymology: a challenge for the theory of metrological traceability

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Traceability of values for catalytic activity concentration of enzymes: a Certified Reference Material for aspartate transaminase.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Protein standardization IV: Value transfer procedure for the assignment of serum protein values from a reference preparation to a target material.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Reference measurement procedure development for C-reactive protein in human serum.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Toward Système International d'Unité-traceable protein quantification: from amino acids to proteins.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

The IFCC Reference Measurement System for HbA1c: a 6-year progress report.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Approved IFCC reference method for the measurement of HbA1c in human blood

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Analytical aspects of molecular Alzheimer's disease biomarkers

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Development and evaluation of a candidate reference measurement procedure for the determination of testosterone in human serum using isotope dilution liquid chromatography/tandem mass spectrometry.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Solid-phase extraction enhances detection of beta-amyloid peptides in plasma and enables Abeta quantification following passive immunization with Abeta antibodies

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

LC-MS/MS for protein and peptide quantification in clinical chemistry

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Quantitation of amyloid beta peptides Aβ(1-38), Aβ(1-40), and Aβ(1-42) in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Characterization of tau in cerebrospinal fluid using mass spectrometry.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Characterization of the New Serum Protein Reference Material ERM-DA470k/IFCC: Value Assignment by Immunoassay

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.39

21 January 2018

Identifiers

10.2217/BMM.12.39

1 reference

Europe PubMed Central

27 August 2017

1 reference

Europe PubMed Central

27 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38037154&oldid=1857630395"